3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
115
Brain Neoplasms
114
Prostatic Neoplasms
101
Neoplasm Metastasis
79
Carcinoma, Hepatocellular
69
Lung Neoplasms
67
Pancreatic Neoplasms
64
Breast Neoplasms
48
Melanoma
37
Carcinoma, Renal Cell
33
Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
21
Colorectal Neoplasms
20
Liver Neoplasms
19
Glioblastoma
18
Small Cell Lung Carcinoma
14
Head and Neck Neoplasms
14
Sarcoma
11
Kidney Neoplasms
11
Glioma
10
Recurrence
8
Urinary Bladder Neoplasms
7
Radiation Injuries
6
Neuroma, Acoustic
6
Cholangiocarcinoma
6
Adenocarcinoma
6
Uveal Melanoma
5
Uterine Cervical Neoplasms
5
Prostate Cancer Metastatic
5
Ovarian Neoplasms
5
Interventions
enzalutamide
6
Abiraterone Acetate
5
abiraterone
2
Prednisone
2
pembrolizumab
1
darolutamide
1
cabazitaxel
1
apalutamide
1
TVB-2640
1
Standard of Care
1
Radiosurgery
1
Pluvicto
1
Photons
1
Omeprazole
1
Nivolumab
1
Ipilimumab
1
Gonadotropin-Releasing Hormone
1
Exome Sequencing
1
Drug Therapy
1
CTLA-4 Antigen
1
Artificial Intelligence
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms, Castration-Resistant
×
Radiosurgery
×
Clear all
NCT06276465
2024-12-20
PEACE8
UNICANCER
Phase 3
Recruiting
336 enrolled